PETS
PETMED EXPRESS INC
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$1.61
−0.62%Sep 17, 2026, 13:11 UTC
Peter Batushansky became Chair of the Corporate Governance and Nominating Committee of PetMed Express Inc., effective September 28, 2026.
Sep 17, 2026, 13:11 UTC
PetMed Express Inc. elected Justin Mennen as Chair of the Board, effective September 28, 2026.
Sep 17, 2026, 13:11 UTC
Leslie C.G. Campbell retired from the PetMed Express Inc. board and resigned as Interim Chief Executive Officer and President, effective September 28, 2026.
Sep 17, 2026, 13:11 UTC
PetMed Express Inc. appointed Jeffrey Allen Willard as Chief Executive Officer and President, effective September 28, 2026.
Aug 13, 2026, 20:05 UTC
PETMED reported first-quarter sales of $41 million.
Aug 10, 2026, 00:00 UTC
Microvision, Inc. appointed Christine Chambers as Chief Financial Officer and principal financial and accounting officer, effective August 27, 2026.
Jul 23, 2026, 12:30 UTC
ClearSign Technologies completed a private placement of 500,000 shares of common stock with an existing stockholder for gross proceeds of $1,770,000.
Jul 23, 2026, 12:00 UTC
PetMeds entered into a definitive agreement for a sale-leaseback of its headquarters and distribution center buildings for $37 million.
Source:Jul 14, 2026, 12:00 UTC
PetMeds launched a new co-branded online pet pharmacy platform with Rural King, making pet medications and health products available to Rural King customers.
Source:Jun 30, 2026, 13:15 UTC
SilverCape Investments Limited made an unsolicited, non-binding, and conditional proposal to acquire all outstanding shares of PetMed Express, Inc. for $3.00 per share in cash.
Source:Jun 29, 2026, 11:27 UTC
SilverCape revised its proposal to acquire PetMed Express.
Source:Jun 5, 2026, 10:16 UTC
PetMed Express reported Q4 earnings with sales above estimates and improved margins.
Source:Jun 2, 2026, 20:05 UTC
PetMed Express, Inc. announced its financial results for the fourth quarter and fiscal year ended March 31, 2026.
Source: